2nd Conference on Innovations in Tuberculosis 2025
Show local (UTC) times
08:25
Opening & Welcome + Session 1: Innovations in TB Diagnostics and Screening - Symtomatic and Asymptomatic TB
08:25
Recent Developments in TB Testing and Screening Technologies, Including for HIV-associated TB and TB in Children
08:25
#1 Development and Internal Evaluation of an AI-Enabled Cough Sound Analysis Model for Tuberculosis Screening in a High-Burden Setting: A Prospective Cross-Sectional Study
Abstract
Mary Kagujje
08:25
#2 A Before-and-After Study Evaluating a Male-Specific Tuberculosis Screening and Diagnosis Intervention in Uganda
Abstract
Jasper Nidoi
08:25
#3 Enhancing TB Case Notification and Screening in Katsina, Northwestern Nigeria: The Impact of CommTb Mobile App Integration
Abstract
Steven Batur
08:25
#4 Diagnostic Accuracy of Xpert MTB/RIF Ultra on Nasopharyngeal Swabs in Adults With Presumptive TB in a High-Burden Setting
Abstract
Robinah Nakawunde
08:25
#24 Optimizing the Implementation and Scale-Up of the WHO Treatment-Decision Algorithms for Children with Pulmonary Tuberculosis in Sub-Saharan Africa
Abstract
Fatuma Said Msafiri
10:30
Coffee Break 1
10:55
Session 2: When Many Epidemics Collide: TB and Comorbidities
10:55
Towards Integrated Prevention, Treatment, and Service Provision for TB, HIV and NCDs
John Ditekemena
10:55
#5 Assessing the Effectiveness of Community-Based TB/HIV Testing in Improving TB/HIV Case Finding: Case Study in North-West Nigeria.
Abstract
Andrew Agbo
11:30
Session 3: THE GREAT DEBATE: Africa Should Move to Whole Genome Sequencing for Drug Resistance Testing?
11:30
Debate: PRO Standpoint
Stefan Niemann
11:30
Debate: CON Standpoint
Bouke de Jong
12:30
Lunch Break
13:25
Session 4: TB Clinical Management: Advanced HIV
13:25
TB meningitis / TB in advanced HIV
Fiona Cresswell
13:25
#6 Prevalence of Tuberculosis and Rifampicin-Resistant Tuberculosis Among Clients With Advanced HIV Disease in Akwa Ibom State, Nigeria: A Retrospective Analysis
Abstract
Othomjah Ibitham
13:25
#44 - Prevalence of Tuberculosis and Determinant Among Adults Newly Diagnosed With HIV at Epako Clinic in Namibia Omaheke Region: A Cross-Sectional Study
Abstract
Kalambayi Francois Lumbala
14:00
Session 5: TB Drug Resistance.
15:00
Coffee Break 2
15:20
Session 6: TB-HIV Drug Interactions and Comorbidities
15:20
Triple Intersection: Exploring the Connections Between Tuberculosis, Takayasu Arteritis, and Sarcoidosis: A Case Report
Ismael Katjitae
15:20
#13 Leveraging eCBSS Data for Geospatial Mapping of Tuberculosis Hotspots and Optimizing the Integrated TB Case Finding (CAST+) Intervention in Eastern Uganda
Abstract
Clark Joshua Brianwong
15:20
#14 Genome-Wide Analyses of Mycobacterium tuberculosis Complex Isolates Reveal Insights Into Circulating Lineages and Drug Resistance Mutations in The Gambia
Abstract
Fatou Faal
15:20
#15 Harnessing Artificial Intelligence to Predict TB Treatment Outcomes in Hiv-co-infected Patients: A Machine Learning Approach
Abstract
Malumo Chitila
15:20
#16 Leveraging Big Microdata to Optimize Social Determinants of Health to End Tuberculosis in Sub-Saharan Africa: Evidence from Lesotho
Abstract
Daniel Ogbuabor
15:20
#34 - Comparative Pharmacokinetics of Dolutegravir in Children With HIV With and Without TB Co-Infection
Abstract
Charles Martyn-Dickens
15:20
#39 Use of Artificial Intelligence (AI)-Driven Technology to Drive TB Case Finding: An Eye Opening Experience From Akwa Ibom State, Nigeria
Abstract
Adekola Adekunle
15:20
#49 - Managing TB/HIV Comorbidities Among Children and Adolescents Co-Infected With TB & HIV Through Targeted Structural Interventions in Northern Nigeria: A Pathway to Improved Health Outcomes
Abstract
Dr. Charles ODIMA
16:00
Session 7: Post-TB Lung Disease.